Clovis Oncology, Inc.
CLVS
CLVS was delisted on the 20th of December, 2022.
176 hedge funds and large institutions have $2.76B invested in Clovis Oncology, Inc. in 2015 Q2 according to their latest regulatory filings, with 40 funds opening new positions, 58 increasing their positions, 55 reducing their positions, and 16 closing their positions.
150% more first-time investments, than exits
New positions opened: 40 | Existing positions closed: 16
18% more funds holding in top 10
Funds holding in top 10: 11 → 13 (+2)
16% more funds holding
Funds holding: 152 → 176 (+24)
15% more capital invested
Capital invested by funds: $2.41B → $2.76B (+$354M)
5% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 55
6% less call options, than puts
Call options by funds: $42.9M | Put options by funds: $45.9M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$38.3M |
| 2 |
CCM
Consonance Capital Management
New York
|
+$25.9M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$25.6M |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$23.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
-$97.6M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$45.3M |
| 3 |
VVM
Versant Venture Management
San Francisco,
California
|
-$34.9M |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$18M |
| 5 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
-$17.2M |
CLVS Hedge Fund Activity: Q2 2015 in Review
176 of the 3,711 institutional investors tracked by Wall St. Rank reported a position in Clovis Oncology, Inc. (CLVS) for Q2 2015, worth a combined $2.76B — up 15% from $2.41B a quarter earlier.
Buyers outnumbered sellers: 40 funds opened new CLVS positions and 16 closed out — a net gain of 24 holders — while 58 added to existing stakes and 55 trimmed.
The largest buyer was PFM Health Sciences, adding an estimated $38.3M. The largest seller was NEA Management Company, cutting an estimated $97.6M.
- 176 institutional investors held Clovis Oncology, Inc. (CLVS) as of Q2 2015, up from 152 in Q1 2015.
- Funds reported $2.76B of Clovis Oncology, Inc. stock for Q2 2015, up 15% quarter-over-quarter.
- 40 funds opened new Clovis Oncology, Inc. positions in Q2 2015 and 16 closed out, a net change of +24 holders.
- The largest Clovis Oncology, Inc. buyer in Q2 2015 was PFM Health Sciences, an estimated $38.3M added.
- The largest Clovis Oncology, Inc. seller in Q2 2015 was NEA Management Company, an estimated $97.6M sold.
Based on aggregated 13F filings for Q2 2015.